Deals Rumor Mill: Lonza Group, IDT, Deutsche Bank
Swiss biotechnology firm Lonza Group AG has made an offer to buy drug development and delivery company Catalent Inc., The New York Times reported on Wednesday. According to the report, Lonza...To view the full article, register now.
Already a subscriber? Click here to view full article